Literature DB >> 6162640

Bleomycin labelled with 99mTc for differentiation of breast tumors.

D Warczyglowa, S Szostak, Z Marzecki, S Tustanowski.   

Abstract

Bleomycin labelled with 99mTc was used to differentiate benign and malignant breast tumors. Breast scintigraphy was performed 15 and 60 min following the IV injection of 5 mCi99mTc bleomycin. Thirty-two patients with breast tumor (14 carcinomas and 18 benign nodular lesions) were examined. Cytologic or histologic verification of the tumor was carried out in all cases. All malignant tumors of the breast in the investigated group of patients revealed significantly increased accumulation of 99mTc-bleomycin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162640     DOI: 10.1007/BF00253714

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  Experimental pertechnetate mammography.

Authors:  R L Villarreal; R W Parkey; F J Bonte
Journal:  Radiology       Date:  1974-06       Impact factor: 11.105

2.  99m Tc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses.

Authors:  E T Cancroft; S J Goldsmith
Journal:  Radiology       Date:  1973-02       Impact factor: 11.105

3.  [Thermography in breast neoplasms. Eight years of clinical experience. Diagnosis, detection, prognosis, monitoring (author's transl)].

Authors:  R Amalric; J M Spitalier
Journal:  Pol Przegl Radiol Med Nukl       Date:  1980 Jan-Feb

4.  A clinical evaluation of indium-111 bleomycin as a tumor-imaging agent.

Authors:  D L Lilien; S E Jones; R E O'Mara; S E Salmon; B G Durie
Journal:  Cancer       Date:  1975-04       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.